Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses » Aspergillosis » Pulmonary Aspergillosis
Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Mycoses » Lung Diseases, Fungal » Pulmonary Aspergillosis
Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Diseases, Fungal » Pulmonary Aspergillosis
Description
Infections of the respiratory tract with fungi of the genus ASPERGILLUS. MeSH
Hierarchy View
Subtype Terms (2)
Aspergillosis, Allergic Bronchopulmonary
15 drugs (13 approved, 2 experimental)
Invasive Pulmonary Aspergillosis
9 drugs (7 approved, 2 experimental)
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (13)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
